| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 1.031 | 4.385 | 6.837 | - |
| Total Income - EUR | - | - | - | - | - | - | 1.359 | 4.929 | 7.652 | - |
| Total Expenses - EUR | - | - | - | - | - | - | 2.412 | 2.505 | 6.648 | - |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -1.053 | 2.424 | 1.004 | - |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -1.084 | 2.295 | 867 | - |
| Employees | - | - | - | - | - | - | 0 | 0 | 0 | - |
Check the financial reports for the company - Toader Bio Tech S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 115 | 0 | 0 | - |
| Current Assets | - | - | - | - | - | - | 2.897 | 2.292 | 33.275 | - |
| Inventories | - | - | - | - | - | - | 1.010 | 507 | 1.169 | - |
| Receivables | - | - | - | - | - | - | 0 | 0 | 0 | - |
| Cash | - | - | - | - | - | - | 1.887 | 1.785 | 21.997 | - |
| Shareholders Funds | - | - | - | - | - | - | -1.043 | 1.249 | 2.112 | - |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | - |
| Debts | - | - | - | - | - | - | 4.056 | 1.043 | 1.145 | - |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 30.018 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "113 - 113" | |||||||||
| CAEN Financial Year |
113
|
|||||||||
Comments - Toader Bio Tech S.r.l.